Blockage of Wnt/β-catenin signaling by quercetin reduces survival and proliferation of B-1 cells in vitro

Immunobiology

Volumn 220, Issue 1, 2015, Pages 60-67

  Novo, Marilia Campos Tavares ^a   Osugui, Lika ^a   dos Reis, Vanessa Oliveira ^a   Longo Maugéri, Ieda Maria ^a   Mariano, Mario ^a   Popi, Ana Flavia ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

B 1 cells; IL 6; Proliferation; Quercetin; Wnt; Catenin

Indexed keywords

BETA CATENIN; INTERLEUKIN 6; QUERCETIN; WNT PROTEIN;

ANIMAL CELL; APOPTOSIS; ARTICLE; AUTOIMMUNE DISEASE; B CELL CULTURE; B LYMPHOCYTE; CELL EXPANSION; CELL SURVIVAL; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; IN VITRO STUDY; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE PROLIFERATION; LYMPHOCYTE SUBPOPULATION; MOUSE; NEOPLASM; NONHUMAN; PERITONEUM CELL; SIGNAL TRANSDUCTION; ANIMAL; CELL LINE; CELL PROLIFERATION; CULTURE TECHNIQUE; DRUG EFFECTS; METABOLISM; WNT SIGNALING PATHWAY;

ANIMALS; B-LYMPHOCYTE SUBSETS; CELL CULTURE TECHNIQUES; CELL LINE; CELL PROLIFERATION; CELL SURVIVAL; FEMALE; INTERLEUKIN-6; MICE; QUERCETIN; WNT SIGNALING PATHWAY;

EID: 84940163799     PISSN: 01712985     EISSN: 18783279     Source Type: Journal    
DOI: 10.1016/j.imbio.2014.09.001     Document Type: Article

References (44)

1. Almeida S.R., Aroeira L.S., Frymuller E., Dias M.A., Bogsan C.S., Lopes J.D., Mariano M. Mouse B-1 cell-derived mononuclear phagocyte, a novel cellular component of acute non-specific inflammatory exudate. Int. Immunol. 2001, 13:1193.
2. Artavanis-Tsakonas S., Rand M.D., Lake R.J. Notch signaling: cell fate control and signal integration in development. Science 1999, 284:770.
3. Bafico A., Gazit A., Wu-Morgan S.S., Yaniv A., Aaronson S.A. Characterization of Wnt-1 and Wnt-2 induced growth alterations and signaling pathways in NIH3T3 fibroblasts. Oncogene 1998, 16:2819.
4. Bergenfelz C., Medrek C., Ekström E., Jirström K., Janols H., Wullt M., Bredberg A., Leandersson K. Wnt5a induces a tolerogenic phenotype of macrophages in sepsis and breast cancer patients. J. Immunol. 2012, 188:5448.
5. Blumenthal A., Ehlers S., Lauber J., Buer J., Lange C., Goldmann T., Heine H., Brandt E., Reiling N. The Wingless homolog WNT5A and its receptor Frizzled-5 regulate inflammatory responses of human mononuclear cells induced by microbial stimulation. Blood 2006, 108:965.
6. Bradley R.S., Brown A.M. A soluble form of Wnt-1 protein with mitogenic activity on mammary epithelial cells. Mol. Cell. Biol. 1995, 15:4616.
7. Cadigan K.M., Nusse R. Wnt signaling: a common theme in animal development. Genes Dev. 1997, 11:3286.
8. Døsen G., Tenstad E., Nygren M.K., Stubberud H., Funderud S., Rian E. Wnt expression and canonical Wnt signaling in human bone marrow B lymphopoiesis. BMC Immunol. 2006, 7:13.
9. Fleming H.E., Janzen V., Lo Celso C., Guo J., Leahy K.M., Kronenberg H.M., Scadden D.T. Wnt signaling in the niche enforces hematopoietic stem cell quiescence and is necessary to preserve self-renewal in vivo. Cell Stem Cell 2008, 2:274.
10. Ge X., Wang X. Role of Wnt canonical pathway in hematological malignancies. J. Hematol. Oncol. 2010, 3:33.
11. Gokbulut A.A., Apohan E., Baran Y. Resveratrol and quercetin-induced apoptosis of human 232B4 chronic lymphocytic leukemia cells by activation of caspase-3 and cell cycle arrest. Hematology 2013, 18:144.
12. Hayward P., Kalmar T., Arias A.M. Wnt/Notch signalling and information processing during development. Development 2008, 135:411.
13. Herzenberg L.A. B-1 cells: the lineage question revisited. Immunol. Rev. 2000, 175:9.
14. Ichii M., Frank M.B., Iozzo R.V., Kincade P.W. The canonical Wnt pathway shapes niches supportive of hematopoietic stem/progenitor cells. Blood 2012, 119:1683.
15. Kim H., Seo E.M., Sharma A.R., Ganbold B., Park J., Sharma G., Kang Y.H., Song D.K., Lee S.S., Nam J.S. Regulation of Wnt signaling activity for growth suppression induced by quercetin in 4T1 murine mammary cancer cells. Int. J. Oncol. 2013, 43:1319.
16. Lam K.P., Rajewsky K. B cell antigen receptor specificity and surface density together determine B-1 versus B-2 cell development. J. Exp. Med. 1999, 190:471.
17. Laurindo M.F.L., Thies F.G., Perez E.C., Novaes e Brito R.R., Mariano M., Popi A.F. B16 melanoma cells increase B-1 cell survival. IL-10 production and radioresistance in vitro. Immunobiology 2013, 218:609.
18. Liang H., Chen Q., Coles A.H., Anderson S.J., Pihan G., Bradley A., Gerstein R., Jurecic R., Jones S.N. Wnt5a inhibits B cell proliferation and functions as a tumor suppressor in hematopoietic tissue. Cancer Cell 2003, 4:349.
19. Logan C.Y., Nusse R. The Wnt signaling pathway in development and disease. Annu. Rev. Cell Dev. Biol. 2004, 20:781.
20. Luis T.C., Weerkamp F., Naber B.A., Baert M.R., de Haas E.F., Nikolic T., Heuvelmans S., De Krijger R.R., Van Dongen J.J., Staal F.J. Wnt3a deficiency irreversibly impairs hematopoietic stem cell self-renewal and leads to defects in progenitor cell differentiation. Blood 2009, 113:546.
21. Luis T.C., Naber B.A., Roozen P.P., Brugman M.H., de Haas E.F., Ghazvini M., Fibbe W.E., Van Dongen J.J., Fodde R., Staal F.J. Canonical wnt signaling regulates hematopoiesis in a dosage-dependent fashion. Cell Stem Cell 2001, 9:345.
22. Mahbub A.A., Le Maitre C.L., Haywood-Small S.L., McDougall G.J., Cross N.A., Jordan-Mahy N. Differential effects of polyphenols on proliferation and apoptosis in human myeloid and lymphoid leukemia cell lines. Anticancer Agents Med. Chem. 2013, 13:1601.
23. McCarthy B.A., Mansour A., Lin Y.C., Kotenko S., Raveche E. RNA interference of IL-10 in leukemic B-1 cells. Cancer Immun. 2004, 4:6.
24. Neumann J., Schaale K., Farhat K., Endermann T., Ulmer A.J., Ehlers S., Reiling N. Frizzled1 is a marker of inflammatory macrophages, and its ligand Wnt3a is involved in reprogramming Mycobacterium tuberculosis-infected macrophages. FASEB J. 2010, 24:4599.
25. Niida A., Hiroko T., Kasai M., Furukawa Y., Nakamura Y., Suzuki Y., Suganom S., Akiyama T. DKK1, a negative regulator of Wnt signaling, is a target of the beta-catenin/TCF pathway. Oncogene 2004, 23:8520.
26. O'Garra A., Chang R., Go N., Hastings R., Haughton G., Howard M. Ly-1 B (B-1) cells are the main source of B cell-derived interleukin 10. Eur. J. Immunol. 1992, 22:711.
27. Park J.W., Kuehn H.S., Kim S.Y., Chung K.M., Choi H., Kim M., Kim J., Lee S.Y., Bae D.S., Jin D.K., Bae Y.S. Downregulation of Wnt-mediated ROS generation is causally implicated in leprechaunism. Mol. Cells 2010, 29:63.
28. Peifer M., Polakis P. Wnt signaling in oncogenesis and embryogenesis - a look outside the nucleus. Science 2000, 287:1606.
29. Pereira C., Schaer D.J., Bachli E.B., Kurrer M.O., Schoedon G. Wnt5A/CaMKII signaling contributes to the inflammatory response of macrophages and is a target for the antiinflammatory action of activated protein C and interleukin-10. Arterioscler. Thromb. Vasc. Biol. 2008, 28:504.
30. Popi A.F., Motta F.L., Mortara R.A., Schenkman S., Lopes J.D., Mariano M. Co-ordinated expression of lymphoid and myeloid specific transcription factors during B-1b cell differentiation into mononuclear phagocytes in vitro. Immunology 2009, 126:114.
31. Radtke F., Clevers H. Self-renewal and cancer of the gut: two sides of a coin. Science 2005, 307:1904.
32. Ranheim E.A., Kwan H.C., Reya T., Wang Y.K., Weissman I.L., Francke U. Frizzled 9 knock-out mice have abnormal B-cell development. Blood 2005, 105:2487.
33. Reya T., O'Riordan M., Okamura R., Devaney E., Willert K., Nusse R., Grosschedl R. Wnt signaling regulates B lymphocyte proliferation through a LEF-1 dependent mechanism. Immunity 2000, 13:15-24.
34. Schmittgen T.D., Livak K.J. Analyzing real-time PCR data by the comparative C(T) method. Nat. Protoc. 2008, 3:1101.
35. Seke Etet P.F., Vecchio L., Nwabo Kamdje A.H. Interactions between bone marrow stromal microenvironment and B-chronic lymphocytic leukemia cells: any role for Notch, Wnt and Hh signaling pathways?. Cell Signal. 2012, 24:1433.
36. Staal F.J., Clevers H.C. WNT signalling and haematopoiesis: a WNT-WNT situation. Nat. Rev. Immunol. 2005, 5:21.
37. Staal F.J., Luis T.C., Tiemessen M.M. WNT signalling in the immune system: WNT is spreading its wings. Nat. Rev. Immunol. 2008, 8:581.
38. Thies F.G., Laurindo M.F., Perez E.C., Novaes e Brito R.R., Mariano M., Popi A.F. Cross talk between peritoneal macrophages and B-1 cells in vitro. PLOS ONE 2013, 8:e62805.
39. Vandesompele J., De Preter K., Pattyn F., Poppe B., Van Roy N., De Paepe A., Speleman F. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol. 2002, 3. RESEARCH0034.
40. Wang Y., Krivtsov A.V., Sinha A.U., North T.E., Goessling W., Feng Z., Zon L.I., Armstrong S.A. The Wnt/beta-catenin pathway is required for the development of leukemia stem cells in AML. Science 2010, 327:1650.
41. Yeung J., Esposito M.T., Gandillet A., Zeisig B.B., Griessinger E., Bonnet D., So C.W. β-Catenin mediates the establishment and drug resistance of MLL leukemic stem cells. Cancer Cell 2010, 18:606.
42. Young C.S., Kitamura M., Hardy S., Kitajewski J. Wnt-1 induces growth, cytosolic beta-catenin, and Tcf/Lef transcriptional activation in Rat-1 fibroblasts. Mol. Cell. Biol. 1998, 18:2474.
43. Zhou J., Cheng P., Youn J.I., Cotter M.J., Gabrilovich D.I. Notch and wingless signaling cooperate in regulation of dendritic cell differentiation. Immunity 2009, 30:845.
44. Zhu Y., Sun Z., Han Q., Liao L., Wang J., Bian C., Li J., Yan X., Liu Y., Shao C., Zhao R.C. Human mesenchymal stem cells inhibit cancer cell proliferation by secreting DKK-1. Leukemia 2009, 23:925.